Facebook
Twitter
Telegram
Report an ErrorBioAtla Balance Sheet 2011-2024 | BCAB
Annual Balance Sheet BioAtla
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-109 M | -212 M | -240 M | -237 M | 14.4 M | 4.14 M | - | - | - | - | - | - | - |
Long Term Debt |
836 K | 2.46 M | 3.98 M | 682 K | 8.41 M | 15 M | - | - | - | - | - | - | - |
Long Term Debt Current |
1.62 M | 1.52 M | 1.39 M | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 2.7 M | 38.6 M | 35.9 M | - | - | - | - | - | - | - |
Total Current Liabilities |
28.3 M | 23.1 M | 19.8 M | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
49 M | 45.4 M | 43.6 M | 35 M | 65.3 M | 45.1 M | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | 19.8 M | 1.42 M | 169 K | - | - | - | - | - | - | - |
Retained Earnings |
-416 M | -293 M | -186 M | -90.9 M | -148 M | -119 M | - | - | - | - | - | - | - |
Total Assets |
120 M | 226 M | 254 M | 245 M | 9.34 M | 16.6 M | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
111 M | 216 M | 245 M | - | - | - | - | - | - | - | - | - | - |
Book Value |
70.7 M | 180 M | 211 M | 210 M | -56 M | -28.4 M | - | - | - | - | - | - | - |
Total Shareholders Equity |
70.7 M | 180 M | 211 M | 210 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet BioAtla
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
415 K | 836 K | 1.25 M | 1.66 M | 2.06 M | 2.46 M | 2.85 M | 3.23 M | 3.61 M | 3.98 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
39.5 M | 49 M | 56.7 M | 55.1 M | 48.1 M | 45.4 M | 46.5 M | 48.5 M | 40.6 M | 43.6 M | 46.9 M | 38.7 M | 33.2 M | 35 M | 35 M | 35 M | 35 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | 19.8 M | 19.8 M | 19.8 M | 19.8 M | 19.8 M | 19.8 M | 19.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-439 M | -416 M | -389 M | -356 M | -320 M | -293 M | -265 M | -239 M | -211 M | -186 M | -163 M | -140 M | -110 M | -90.9 M | -90.9 M | -90.9 M | -90.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
89.2 M | 120 M | 151 M | 180 M | 205 M | 226 M | 189 M | 213 M | 231 M | 254 M | 278 M | 217 M | 229 M | 245 M | 245 M | 245 M | 245 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
80.6 M | 111 M | 141 M | 169 M | 193 M | 216 M | 178 M | 202 M | 219 M | 245 M | 270 M | 208 M | 221 M | 239 M | 239 M | 239 M | 239 M | 3.7 M | - | - | - | 10.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
49.7 M | 70.7 M | 94.7 M | 125 M | 156 M | 180 M | 143 M | 165 M | 190 M | 211 M | 231 M | 178 M | 196 M | 210 M | 210 M | 210 M | 210 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
49.7 M | 70.7 M | 94.7 M | 125 M | 156 M | 180 M | 143 M | 165 M | 190 M | 211 M | 231 M | 178 M | 196 M | 210 M | 210 M | 210 M | 210 M | -56 M | - | - | - | -28.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency